| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 59651-797-01 | 59651-797 | HUMAN PRESCRIPTION DRUG | FUROSEMIDE | FUROSEMIDE | TABLET | ORAL | 20250717 | N/A | ANDA | ANDA218831 | Aurobindo Pharma Limited | FUROSEMIDE | 40 mg/1 | 100 TABLET in 1 BOTTLE (59651-797-01) |
| 59651-797-99 | 59651-797 | HUMAN PRESCRIPTION DRUG | FUROSEMIDE | FUROSEMIDE | TABLET | ORAL | 20250717 | N/A | ANDA | ANDA218831 | Aurobindo Pharma Limited | FUROSEMIDE | 40 mg/1 | 1000 TABLET in 1 BOTTLE (59651-797-99) |
| 59651-796-01 | 59651-796 | HUMAN PRESCRIPTION DRUG | FUROSEMIDE | FUROSEMIDE | TABLET | ORAL | 20250717 | N/A | ANDA | ANDA218831 | Aurobindo Pharma Limited | FUROSEMIDE | 20 mg/1 | 100 TABLET in 1 BOTTLE (59651-796-01) |
| 59651-796-99 | 59651-796 | HUMAN PRESCRIPTION DRUG | FUROSEMIDE | FUROSEMIDE | TABLET | ORAL | 20250717 | N/A | ANDA | ANDA218831 | Aurobindo Pharma Limited | FUROSEMIDE | 20 mg/1 | 1000 TABLET in 1 BOTTLE (59651-796-99) |
| 59651-798-01 | 59651-798 | HUMAN PRESCRIPTION DRUG | FUROSEMIDE | FUROSEMIDE | TABLET | ORAL | 20250717 | N/A | ANDA | ANDA218831 | Aurobindo Pharma Limited | FUROSEMIDE | 80 mg/1 | 100 TABLET in 1 BOTTLE (59651-798-01) |
| 59651-798-05 | 59651-798 | HUMAN PRESCRIPTION DRUG | FUROSEMIDE | FUROSEMIDE | TABLET | ORAL | 20250717 | N/A | ANDA | ANDA218831 | Aurobindo Pharma Limited | FUROSEMIDE | 80 mg/1 | 500 TABLET in 1 BOTTLE (59651-798-05) |